Chemical Compound
[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] acetate
CAS Registry Number
24916-51-6
Primary record
[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] acetate
- 库存
- 9,366 克
- 纯度
- 99.5 %
- CAS
- 24916-51-6
化合物标识与属性
- CAS
- 24916-51-6
- PubChem CID
- 49787020
- SMILES
- C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)N(C)C
- Canonical SMILES
- CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1OC(C)=O
名称与同义词
- acetylspiramycin
- Spiramycin II
- Foromacidin B
- Spiramycin 2
- Acetyl Spiramycin
- Foromacidine B
- Spiramycin B
- Acetylspiramycinum
- Acetylspiramycin (ASPM)
- ASPM
- 24916-51-6
- Acetylspiramycin (TN)
- Acetylspiramycin [JAN]
- A-SPM
- RefChem:184730
- Acetylspiramycin (JP16)
- Acetylspiramycin (JP18)
- SPIRAMYCIN II [MI]
- Spiramycin II;Foromacidin B
- DTXSID4023595
- C45H76N2O15
- UNII-05298J5WMU
- MFCD01684079
- 05298J5WMU
- DTXCID003595
- orb1308201
- SPIRAMYCIN 2 [WHO-DD]
- CHEMBL4303354
- SCHEMBL30211193
- CHEBI:31168
- MolPort-006-069-287
- ZPCCSZFPOXBNDL-TXJOLGFOSA-N
- ZPCCSZFPOXBNDL-ZSTSFXQOSA-N
- HY-B1916
- BBF-03461
- s3618
- AKOS030573278
- ZINC253476106
- AA17042
- C45-H76-N2-O15
- CCG-270557
- CS-8190
- CS-O-05995
- Acetylspiramycin - Mixture of components
- AC-32597
- CID:49787020
- SID:134222452
- FT-0661363
- C12891
- D02420
- 916A516
- C033163
- SR-01000872573
- A1202148
- SR-01000872573-1
- [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] acetate
- Leucomycin V, 9-O-(5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl)-, 3-acetate
- ((4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-((2S,3R,4R,5S,6R)-5-((2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-tetrahydropyran-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yl)oxy-10-((2R,5S,6R)-5-(dimethylamino)-6-methyl-tetrahydropyran-2-yl)oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl) acetate
- ((4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-((2S,3R,4R,5S,6R)-5-((2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl)oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl)oxy-10-((2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl)oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl) acetate
- [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] acetate
- 9-O-[(2R,5S,6R)-5-(Dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-3-acetate-leucomycin V
- Leucomycin V, 9-O-[(2R,5S,6R)-5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-, 3-acetate
- Leucomycin V, 9-O-[5-(dimethylamino)tetrahydro-6-methyl-2H-pyran-2-yl]-, 3-acetate, [9(5S,6R)]-